Allogeneic limbo-deep anterior lamellar keratoplasty (Limbo-DALK)—A novel surgical technique in corneal stromal disease and limbal stem cell deficiency
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0298241 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Verena Schöneberger und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany. Hauptthemen laut MEDLINE: Limbal Stem Cell Deficiency, Corneal Diseases, Corneal Transplantation, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Horizon 2020, EU COST.
Abstract (Originalsprache)
Purpose
To describe a novel corneal surgical technique combining Deep Anterior Lamellar Keratoplasty (DALK) with grafting of allogeneic limbus (Limbo-DALK) for the treatment of eyes with corneal stromal pathology and limbal stem cell deficiency (LSCD).
Methods
Clinical records of six Limbo-DALKs performed in five patients diagnosed with LSCD and corneal stromal pathology requiring keratoplasty were retrospectively reviewed. All patients were diagnosed with LSCD due to various pathologies including thermal and chemical burns, congenital aniridia or chronic inflammatory ocular surface disease. Parameters analysed included demographics, diagnoses, clinical history, thickness measurements using anterior segment OCT, visual acuity, and epithelial status. Regular follow-up visits were scheduled at 6 weeks as well as 3, 6, 9, and 12 and 18 months postoperatively. Main outcome measures were time to graft epithelialisation and the occurrence of corneal endothelial decompensation.
Results
Two grafts showed complete epithelial closure at 2 days, two at 14 days. In one eye, complete epithelial closure was not achieved after the first Limbo-DALK, but was achieved one month after the second Limbo-DALK. No endothelial decompensation occurred except in one patient with silicone oil associated keratopathy. Endothelial graft rejection was not observed in any of the grafts.
Conclusion
Based on the data from this pilot series, limbo-DALK appears to be a viable surgical approach for eyes with severe LSCD and corneal stromal pathology, suitable for emergency situations (e.g. corneal ulceration with impending corneal perforation), while minimising the risk of corneal endothelial decompensation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Ophthalmology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
- Department of Ophthalmology, University Medical Centre Rostock, Rostock, Germany.
ORCID-Profile: Verena Schöneberger
Förderung
- Deutsche Forschungsgemeinschaft
- Horizon 2020
- EU COST
Zitieren
APA
Schöneberger, V., Tahmaz, V., Matthaei, M., Roters, S., Schlereth, S. L., Schaub, F., Cursiefen, C., & Bachmann, B. O. (2024). Allogeneic limbo-deep anterior lamellar keratoplasty (Limbo-DALK)—A novel surgical technique in corneal stromal disease and limbal stem cell deficiency. PLOS ONE. https://doi.org/10.1371/journal.pone.0298241
Vancouver
Schöneberger V, Tahmaz V, Matthaei M, Roters S, Schlereth SL, Schaub F, et al. Allogeneic limbo-deep anterior lamellar keratoplasty (Limbo-DALK)—A novel surgical technique in corneal stromal disease and limbal stem cell deficiency. PLOS ONE. 2024. doi:10.1371/journal.pone.0298241
BibTeX
@article{Schneberger2024,
author = {Schöneberger, Verena and Tahmaz, Volkan and Matthaei, Mario and Roters, Sigrid and Schlereth, Simona L and Schaub, Friederike and Cursiefen, Claus and Bachmann, Björn O},
title = {Allogeneic limbo-deep anterior lamellar keratoplasty (Limbo-DALK)—A novel surgical technique in corneal stromal disease and limbal stem cell deficiency},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0298241}
}
EUVIMED